ResearcherHarvard UniversityActive in the last 2 years
Shadi Abdar Esfahani
Matched on ORCID iD 0000-0002-6077-4580; OpenAlex author ID A5058727171; NIH RePORTER profile ID 12645004. Sources: ClinicalTrials.gov.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 1
- Labs led
- 1
- Collaborators
- 14
2020: 1 trial · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 grant
Papers 2
- Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-23-3548↗
- Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies. Co-author DOI 10.7150/thno.100116↗
Trials 1
Grants 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael D. Lanuti · 1 shared paper, 1 shared trial, 2020–2024 · strength 0.51
- Peter D. Caravan · 2 shared papers, 2024 · strength 0.35
- Hua Ma · 2 shared papers, 2024 · strength 0.35
- Kenneth K. Tanabe · 2 shared papers, 2024 · strength 0.35
- Andrew Scott Liss · 1 shared paper, 2024 · strength 0.20
- David Tsai Ting · 1 shared paper, 2024 · strength 0.15
- Theodore Sunki Hong · 1 shared paper, 2024 · strength 0.15
- Carlos Fernández-del Castillo · 1 shared paper, 2024 · strength 0.15
- Onofrio A. Catalano · 1 shared paper, 2024 · strength 0.15
- Genevieve Marie Boland · 1 shared paper, 2024 · strength 0.15
- Hannah Johnson Roberts · 1 shared paper, 2024 · strength 0.15
- Motaz Qadan · 1 shared paper, 2024 · strength 0.15
- Aparna R. Parikh · 1 shared paper, 2024 · strength 0.15
- Colin D. Weekes · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.